Patient recruitment

Velocity Clinical Research strengthens management team amid European expansion

Retrieved on: 
Thursday, August 12, 2021

DURHAM, NC., Aug. 12, 2021 /PRNewswire/ -- The world's largest integrated clinical trial site organisation, Velocity Clinical Research ("Velocity"), today announces it has strengthened its management team as it embarks on European expansion.

Key Points: 
  • DURHAM, NC., Aug. 12, 2021 /PRNewswire/ -- The world's largest integrated clinical trial site organisation, Velocity Clinical Research ("Velocity"), today announces it has strengthened its management team as it embarks on European expansion.
  • Dr G. Paul Evans, Chief Executive and President of Velocity Clinical Research, said, "Velocity is carving out a new category of pharma services.
  • The clinical trials site landscape will look very different in the next 12 months and Velocity is well placed to take advantage of this consolidation in the market.
  • Dominic Clavell joins Velocity to head up its European operations after a decorated career in some of the top clinical research organisations, site management organisations and pharmaceutical companies in the world, such as Parexel, IQVIA, Synexus and Novartis.

Real Chemistry’s IPM.ai Accelerates the Clinical Investigation and Commercialization of Life-Saving Precision Medicines by Applying AI and ML to Real-World Data

Retrieved on: 
Thursday, July 29, 2021

Life science customers can use The Real Chemistry Clinical Trial Recruitment System to efficiently and effectively find medically-eligible patients within their healthcare ecosystems.

Key Points: 
  • Life science customers can use The Real Chemistry Clinical Trial Recruitment System to efficiently and effectively find medically-eligible patients within their healthcare ecosystems.
  • This technology-based approach is designed to accelerate clinical investigations and lead to faster patient outcomes with less risk.
  • "With 90% of clinical evaluations for rare diseases failing to meet patient recruitment goals, a new approach is needed," said IPM.ai Co-Founder and President Ron Elwell.
  • The traditional strategies used for high prevalence, highly diagnosed diseases have proven ineffective for uncommon conditions, which is why our transformative approach rewrites the clinical recruitment playbook for specialty medicines.

Patients Rate their Clinical Trial Experience Positively, but Trial Locations Still Pose Barriers to Enrollment

Retrieved on: 
Tuesday, July 27, 2021

Our study found that individuals are generally pleased with their clinical trial experience, but organizers could benefit from working more closely with physicians and being strategic about trial locations to boost enrollment and increase accessibility.

Key Points: 
  • Our study found that individuals are generally pleased with their clinical trial experience, but organizers could benefit from working more closely with physicians and being strategic about trial locations to boost enrollment and increase accessibility.
  • Considering the patient experience in the design of clinical trials is essential, said Pam Cusick, Senior Vice President of Rare Patient Voice.
  • Even though personal physicians may not be directly involved in ongoing clinical trials, they do drive the majority of patient enrollment.
  • According to the survey, nearly half (48%) of respondents who had participated in a clinical trial found out about the trial through their physician.

Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcomes

Retrieved on: 
Monday, July 19, 2021

Parexel streamlines clients' clinical development programs, enabling them to navigate market, regulatory, and patient access-related challenges seamlessly.

Key Points: 
  • Parexel streamlines clients' clinical development programs, enabling them to navigate market, regulatory, and patient access-related challenges seamlessly.
  • "Parexel employs a dedicated project team to incorporate patient insights into trial planning, design, and execution.
  • "Ultimately, it improves trial participation rates and patient engagements to increase patient recruitment and retention; thus, driving better outcomes and trial success rates."
  • With a heightened focus on patient-centricity, real-world data, real-world evidence, precision medicine, and adaptive and flexible trial design, Parexel established a Patient Innovation Center (PIC).

Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcomes

Retrieved on: 
Monday, July 19, 2021

Parexel streamlines clients' clinical development programs, enabling them to navigate market, regulatory, and patient access-related challenges seamlessly.

Key Points: 
  • Parexel streamlines clients' clinical development programs, enabling them to navigate market, regulatory, and patient access-related challenges seamlessly.
  • "Parexel employs a dedicated project team to incorporate patient insights into trial planning, design, and execution.
  • "Ultimately, it improves trial participation rates and patient engagements to increase patient recruitment and retention; thus, driving better outcomes and trial success rates."
  • With a heightened focus on patient-centricity, real-world data, real-world evidence, precision medicine, and adaptive and flexible trial design, Parexel established a Patient Innovation Center (PIC).

The Patient Recruiting Agency, LLC Announces Enrollment Launched for the CTP-543 THRIVE Clinical Program Investigating Oral Treatment for Moderate to Severe Alopecia Areata

Retrieved on: 
Thursday, July 8, 2021

The Patient Recruiting Agency announces open enrollment for the THRIVE Clinical Program, a series of clinical trials exploring the investigational product CTP-543 for the potential oral treatment of moderate to severe alopecia areata.

Key Points: 
  • The Patient Recruiting Agency announces open enrollment for the THRIVE Clinical Program, a series of clinical trials exploring the investigational product CTP-543 for the potential oral treatment of moderate to severe alopecia areata.
  • The purpose of the ongoing THRIVE Clinical Program is to measure the effect of CTP-543 on hair regrowth and to evaluate safety in people with alopecia areata.
  • The THRIVE Clinical Program is now enrolling adults 18 to 65 years old with at least 50% scalp hair loss due to alopecia areata.
  • US Thrive Clinical Program Website: https://www.mythrivestudy.com
    Canadian Thrive Clinical Program Website: https://www.mythrivestudy.ca
    Located in Austin, Texas, The Patient Recruiting Agency (TPRA) supports Sponsors, CROs, SMOs, and Investigators with patient recruitment services.

Global Atrophy Clinical Trials Review, H1 2021 Report: Trial Status, Trial Phase, Sponsor Type and End Point Status - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 30, 2021

The "Atrophy - Global Clinical Trials Review, H1, 2021" clinical trials has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Atrophy - Global Clinical Trials Review, H1, 2021" clinical trials has been added to ResearchAndMarkets.com's offering.
  • This report presents top line data relating to the clinical trials on Atrophy.
  • Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
  • The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Deep 6 AI Announces Substantial Expansion of its Innovative AI-Based Clinical Trial Acceleration Software and Research Ecosystem

Retrieved on: 
Tuesday, June 29, 2021

Deep 6 AI, the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS), today announced significant growth with the addition of key customer wins and an expanding executive leadership team.

Key Points: 
  • Deep 6 AI, the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS), today announced significant growth with the addition of key customer wins and an expanding executive leadership team.
  • I started Deep 6 AI in 2016 to use the power of AI to rethink patient recruitment and trial feasibility in clinical research, said Wout Brusselaers, CEO of Deep 6 AI.
  • Deep 6 AI develops clinical trial acceleration software to bring the right therapies to patients faster.
  • The platform connects sponsors, clinical researchers, physicians, and patients in a rapidly growing real-world ecosystem of premier research organizations.

Leading Patient Recruitment Companies CSSi and Patient Advertising Guru Announce Merger

Retrieved on: 
Monday, June 28, 2021

GLEN BURNIE, Md., June 28, 2021 /PRNewswire/ -- CSSi and Patient Advertising Guru, leading patient recruitment vendors, today announce the merger of the two companies, bringing together two best-in-class providers to better serve the recruitment needs of sponsors, CROs, and sites in the pharmaceutical industry.

Key Points: 
  • GLEN BURNIE, Md., June 28, 2021 /PRNewswire/ -- CSSi and Patient Advertising Guru, leading patient recruitment vendors, today announce the merger of the two companies, bringing together two best-in-class providers to better serve the recruitment needs of sponsors, CROs, and sites in the pharmaceutical industry.
  • The company will combine Patient Advertising Guru's expertise in advertising planning and placement for clinical trial recruitment with CSSi's unmatched global patient recruitment and retention services.
  • "The merger of these two patient recruitment companies is extremently significant," said Evan Brett, President of Patient Advertising Guru.
  • Patient Advertising Guru is a niche provider of advertising and media buying services that exclusively serves the healthcare industry.

Elligo Health Research Acquires Root Health as Growth Accelerates

Retrieved on: 
Tuesday, June 8, 2021

Elligo Health Research today announced the acquisition of Root Health , an AI virtual assistant for clinical research.

Key Points: 
  • Elligo Health Research today announced the acquisition of Root Health , an AI virtual assistant for clinical research.
  • Root Healths AI virtual assistant fits seamlessly with Elligos proprietary IntElligo Research Stack, said Root Health CEO Raj Sharma.
  • Root Health was built to improve the patients experience in clinical trials while accelerating patient recruitment.
  • Elligo Health Research , a healthcare-enabling research organization, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option.